Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support With Fresh Plasma, on Any Patient With VTE Suspicion

NCT06480994 is registered in ClinicalTrials.gov with Diagnostica Stago R&D as lead sponsor.

NCT NCT06480994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06480994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support With Fresh Plasma, on Any Patient With VTE Suspicion
Lead sponsor
Diagnostica Stago R&D
Phase
Observational
Overall status
Recruiting
Start date
June 21, 2022
Completion date
February 28, 2027
Enrollment
1,836 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary embolism, venous thromboembolism